One study in patients with depressive disorders demonstrated that intranasal oxytocin enhanced state anxiety, and, in patients with higher levels of depression, decreased non-verbal flight behaviour in a mock psychotherapy session in which patients were asked to disclose personal information [68]. This evidence concerns the gene OXT and depressive symptom measurement.